![Maya Chkaiban](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Maya Chkaiban
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Jeito Capital SASU
![]() Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France.
6
| Private Company | Investment Managers | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Maya Chkaiban tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Turenne Capital Partenaires SA
![]() Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Analyst | |
Neogene Therapeutics, Inc.
![]() Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
New York University School of Law | College/University | Graduate Degree | |
Stanford University | College/University | Undergraduate Degree | |
Human Immunology Biosciences, Inc.
![]() Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
SparingVision SAS
![]() SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
NMD Pharma A/S
![]() NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member | |
Eyebiotech Ltd.
![]() Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Francia | 3 |
Danimarca | 2 |
Regno Unito | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Posizioni
Director/Board Member | 6 |
Private Equity Investor | 5 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Maya Chkaiban
- Connessioni Società